How is the Donepezil Market Poised for Growth: Trends and Opportunities Through 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the donepezil market?
In recent times, the market size for donepezil has experienced significant growth. It’s expected to increase from $1.00 billion in 2024 to $1.05 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth during the historic period include higher instances of Alzheimer’s disease, an expanding elderly population, increased government spending and initiatives, greater understanding of neurodegenerative disorders, and a surge in the requirement for nucleic acid samples of superior quality.
What will be the donepezil market size in the future?
Anticipations for a consistent expansion for the donepezil market in the following years are high, with projections at $1.27 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.9%. The escalation during this prospective span can be tied to factors such as an increase in health care spending, heightened emphasis on early Alzheimer’s detection, a rising demand for combined treatment methods, enhanced investment in health care infrastructure, and increasing awareness about neurodegenerative diseases. Key trends for this period incorporate developments in drug formulations and delivery methods, technology advancements, the introduction of new dosage forms and formulations, the authorization of generic donepezil versions, and superior research facilities.
Get your donepezil market report here!
https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report
What main drivers are fueling expansion in the donepezil market?
The surge in Alzheimer’s disease instances is projected to drive the expansion of the donepezil market further. Alzheimer’s disease, a progressive neurological condition that results in brain cell death and degeneration, triggers memory loss, cognitive impairment, and alterations in behavior. The rise in Alzheimer’s cases can be attributed to numerous factors, including an aging populace, population growth, lifestyle-related aspects, an escalation in chronic illnesses, genetic elements, and environmental exposure. Donepezil functions as an efficient treatment for Alzheimer’s by improving cognitive abilities and day-to-day life skills by influencing acetylcholine levels in the brain. For example, a May 2024 report from the Alzheimer’s Association, a US nonprofit organization focused on Alzheimer’s patient care, support, and research, stated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to a projected 6.9 million in 2024. Thus, the escalating occurrence of alzheimer’s is fueling the expansion of the donepezil market.
What key areas define the segmentation of the global donepezil market?
The donepezil market covered in this report is segmented –
1) By Type: 5mg, 10mg, 23mg
2) By Route Of Administration: Oral, Transdermal
3) By Application: Hospitals, Clinics, Drugstore
Subsegments:
1) By 5mg: Immediate-Release 5mg, Orally Disintegrating 5mg
2) By 10mg: Immediate-Release 10mg, Orally Disintegrating 10mg
3) By 23mg: Extended-Release 23mg, Film-Coated 23mg
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp
Who are the dominant players expanding their reach in the donepezil market?
Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy’s Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group
How are evolving market trends shaping donepezil Strategies?
Leading businesses functioning in the donepezil market are zeroing in on creating innovative technologies such as the donepezil system, a strategy designed to increase patient adherence and boost the success of the treatment using inventive formulations like extended-release. Donepezil works as a system for the pharmacological method or action plan of donepezil, a drug primarily prescribed for Alzheimer’s disease and other types of dementia. For example, the US-based biopharmaceutical firm Corium Innovation Inc., in October 2022, introduced a donepezil transdermal system dubbed Adlarity for the treatment of patients struggling with mild to severe Alzheimer disease (AD) dementia. This novel transdermal formula of donepezil allows the drug to be delivered directly through the skin, avoiding the digestive system and significantly diminishing the chances of gastrointestinal side effects. It also provides a more user-friendly mode of administration, serving both Alzheimer’s patients and their caregivers.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21174
Which regions are emerging as leaders in the donepezil market?
North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Crohn’S Disease CD Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
Gastroesophageal Reflux Disease (GERD) Global Market Report 2025
Gene Therapy Global Market Report 2025
https://thebusinessresearchcompany.com/report/genes-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
